368 related articles for article (PubMed ID: 36395147)
21. Key Peptides and Proteins in Alzheimer's Disease.
Penke B; Bogár F; Paragi G; Gera J; Fülöp L
Curr Protein Pept Sci; 2019; 20(6):577-599. PubMed ID: 30605056
[TBL] [Abstract][Full Text] [Related]
22. Targeting Infectious Agents as a Therapeutic Strategy in Alzheimer's Disease.
Fülöp T; Munawara U; Larbi A; Desroches M; Rodrigues S; Catanzaro M; Guidolin A; Khalil A; Bernier F; Barron AE; Hirokawa K; Beauregard PB; Dumoulin D; Bellenger JP; Witkowski JM; Frost E
CNS Drugs; 2020 Jul; 34(7):673-695. PubMed ID: 32458360
[TBL] [Abstract][Full Text] [Related]
23. Alzheimer's Amyloid-β is an Antimicrobial Peptide: A Review of the Evidence.
Gosztyla ML; Brothers HM; Robinson SR
J Alzheimers Dis; 2018; 62(4):1495-1506. PubMed ID: 29504537
[TBL] [Abstract][Full Text] [Related]
24. The possible role of the immune system in Alzheimer's disease.
Marx F; Blasko I; Pavelka M; Grubeck-Loebenstein B
Exp Gerontol; 1998; 33(7-8):871-81. PubMed ID: 9951630
[TBL] [Abstract][Full Text] [Related]
25. Neurons derived from sporadic Alzheimer's disease iPSCs reveal elevated TAU hyperphosphorylation, increased amyloid levels, and GSK3B activation.
Ochalek A; Mihalik B; Avci HX; Chandrasekaran A; Téglási A; Bock I; Giudice ML; Táncos Z; Molnár K; László L; Nielsen JE; Holst B; Freude K; Hyttel P; Kobolák J; Dinnyés A
Alzheimers Res Ther; 2017 Dec; 9(1):90. PubMed ID: 29191219
[TBL] [Abstract][Full Text] [Related]
26. Regional distribution of synaptic markers and APP correlate with distinct clinicopathological features in sporadic and familial Alzheimer's disease.
Shinohara M; Fujioka S; Murray ME; Wojtas A; Baker M; Rovelet-Lecrux A; Rademakers R; Das P; Parisi JE; Graff-Radford NR; Petersen RC; Dickson DW; Bu G
Brain; 2014 May; 137(Pt 5):1533-49. PubMed ID: 24625695
[TBL] [Abstract][Full Text] [Related]
27. Reassessing the amyloid cascade hypothesis of Alzheimer's disease.
Pimplikar SW
Int J Biochem Cell Biol; 2009 Jun; 41(6):1261-8. PubMed ID: 19124085
[TBL] [Abstract][Full Text] [Related]
28. Probing amyloid-β pathology in transgenic Alzheimer's disease (tgArcSwe) mice using MALDI imaging mass spectrometry.
Carlred L; Michno W; Kaya I; Sjövall P; Syvänen S; Hanrieder J
J Neurochem; 2016 Aug; 138(3):469-78. PubMed ID: 27115712
[TBL] [Abstract][Full Text] [Related]
29. The Structure and Function of α, β and γ-Secretase as Therapeutic Target Enzymes in the Development of Alzheimer's Disease: A Review.
Ahmad SS; Khan S; Kamal MA; Wasi U
CNS Neurol Disord Drug Targets; 2019; 18(9):657-667. PubMed ID: 31608840
[TBL] [Abstract][Full Text] [Related]
30. Alzheimer’s disease, cerebrovascular disease, and the β-amyloid cascade.
Honjo K; Black SE; Verhoeff NP
Can J Neurol Sci; 2012 Nov; 39(6):712-28. PubMed ID: 23227576
[TBL] [Abstract][Full Text] [Related]
31. G protein-coupled receptor kinases are associated with Alzheimer's disease pathology.
Guimarães TR; Swanson E; Kofler J; Thathiah A
Neuropathol Appl Neurobiol; 2021 Dec; 47(7):942-957. PubMed ID: 34164834
[TBL] [Abstract][Full Text] [Related]
32. The Y
Matrone C; Iannuzzi F; Annunziato L
Ageing Res Rev; 2019 Jul; 52():120-128. PubMed ID: 31039414
[TBL] [Abstract][Full Text] [Related]
33. Aβ-induced acceleration of Alzheimer-related τ-pathology spreading and its association with prion protein.
Gomes LA; Hipp SA; Rijal Upadhaya A; Balakrishnan K; Ospitalieri S; Koper MJ; Largo-Barrientos P; Uytterhoeven V; Reichwald J; Rabe S; Vandenberghe R; von Arnim CAF; Tousseyn T; Feederle R; Giudici C; Willem M; Staufenbiel M; Thal DR
Acta Neuropathol; 2019 Dec; 138(6):913-941. PubMed ID: 31414210
[TBL] [Abstract][Full Text] [Related]
34. The Dynamics of β-Amyloid Proteoforms Accumulation in the Brain of a 5xFAD Mouse Model of Alzheimer's Disease.
Bugrova AE; Strelnikova PA; Indeykina MI; Kononikhin AS; Zakharova NV; Brzhozovskiy AG; Barykin EP; Pekov SI; Gavrish MS; Babaev AA; Kosyreva AM; Morozova AY; Degterev DA; Mitkevich VA; Popov IA; Makarov AA; Nikolaev EN
Int J Mol Sci; 2021 Dec; 23(1):. PubMed ID: 35008451
[TBL] [Abstract][Full Text] [Related]
35. Alzheimer's disease: many failed trials, so where do we go from here?
Reiss AB; Glass AD; Wisniewski T; Wolozin B; Gomolin IH; Pinkhasov A; De Leon J; Stecker MM
J Investig Med; 2020 Aug; 68(6):1135-1140. PubMed ID: 32699179
[TBL] [Abstract][Full Text] [Related]
36. Rho-associated protein kinase 1 (ROCK1) is increased in Alzheimer's disease and ROCK1 depletion reduces amyloid-β levels in brain.
Henderson BW; Gentry EG; Rush T; Troncoso JC; Thambisetty M; Montine TJ; Herskowitz JH
J Neurochem; 2016 Aug; 138(4):525-31. PubMed ID: 27246255
[TBL] [Abstract][Full Text] [Related]
37. Activation of Ras-ERK Signaling and GSK-3 by Amyloid Precursor Protein and Amyloid Beta Facilitates Neurodegeneration in Alzheimer's Disease.
Kirouac L; Rajic AJ; Cribbs DH; Padmanabhan J
eNeuro; 2017; 4(2):. PubMed ID: 28374012
[TBL] [Abstract][Full Text] [Related]
38. Distribution of beta/A4 protein and amyloid precursor protein in hereditary cerebral hemorrhage with amyloidosis-Dutch type and Alzheimer's disease.
Rozemuller AJ; Roos RA; Bots GT; Kamphorst W; Eikelenboom P; Van Nostrand WE
Am J Pathol; 1993 May; 142(5):1449-57. PubMed ID: 7684195
[TBL] [Abstract][Full Text] [Related]
39. Reduction of the expression of the late-onset Alzheimer's disease (AD) risk-factor
Andrew RJ; De Rossi P; Nguyen P; Kowalski HR; Recupero AJ; Guerbette T; Krause SV; Rice RC; Laury-Kleintop L; Wagner SL; Thinakaran G
J Biol Chem; 2019 Mar; 294(12):4477-4487. PubMed ID: 30692199
[TBL] [Abstract][Full Text] [Related]
40. Upregulation of Alzheimer's Disease Amyloid-β Protein Precursor in Astrocytes Both in vitro and in vivo.
Liang Y; Raven F; Ward JF; Zhen S; Zhang S; Sun H; Miller SJ; Choi SH; Tanzi RE; Zhang C
J Alzheimers Dis; 2020; 76(3):1071-1082. PubMed ID: 32597805
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
